ALUNBRIG is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test. 90 mg orally once daily for the first 7 days; then increase to 180 mg orally once daily. May be taken with or without food.<\/p>\n
ALUNBRIG (brigatinib) tablets, for oral use Initial U.S. Approval: 2017
\nTo access brigatinib tablets sold under the brand name can be made available on request to patient if the drug has not been approved or is not available in your country. For information or advice, call IPN’s Pharmaceutical Expert. Our expert will be happy to take your query and guide with an effective solution. Be free and call today for full support at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj)<\/p>\n","protected":false},"excerpt":{"rendered":"
How to access Alunbrig (brigatinib): You can access Alunbrig (brigatinib) from everyone.org if the drug has not been approved or is not available in your country. We help patients and doctors get access to medicines at the lowest price worldwide.<\/p>\n
Disease Indications-Lung Cancer If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import \u201cbrigatinib tablets\u201d based on the information you provide.<\/strong><\/p>\n
\nManufacturer-ARIAD Pharmaceuticals, Inc.
\nUsage-Oral
\nMedicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Pharmaceuticals and Medical Devices Agency (PMDA)
\nSummary of FDA-approved use on approval date: Click Here<\/a>
\n(see Drugs@FDA for complete indication)<\/p>\nAccess the best support services globally<\/h4>\n